Clinical trial
Tigecycline In-Vitro Surveillance Study In Taiwan
NCT00488397 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00488397 |
|---|---|
| Title | Tigecycline In-Vitro Surveillance Study In Taiwan |
| Official title | Tigecycline In-Vitro Surveillance Study In Taiwan |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Community Acquired Infections |
| Intervention type | Other |
| Interventions | In-vitro testing |
| Enrollment | 7,902 |
| Start date | Aug 1, 2006 |
| Primary completion | Feb 1, 2011 |
| Completion | Feb 1, 2011 |
| First posted | Jun 20, 2007 |
| Last update posted | Mar 22, 2011 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: